Reta GLP-3 (Retatrutide) – 10mg

Description

Retatrutide 10mg represents the next generation of metabolic research as a “triple agonist” peptide. This 10mg lyophilized vial is engineered for high-precision studies into the simultaneous activation of the Glucagon-Like Peptide-1 (GLP-1), Glucose-Dependent Insulinotropic Polypeptide (GIP), and Glucagon (GCG) receptors.

By targeting three distinct hormonal pathways, Retatrutide offers researchers a unique tool for investigating unprecedented levels of metabolic regulation, energy expenditure, and glycemic control.